Indian Journal of Nuclear Medicine

COMMENTARY
Year
: 2020  |  Volume : 35  |  Issue : 1  |  Page : 1--3

Inclusion of radiopharmaceuticals in the Indian pharmacopeia: A step forward


Bikash Ranjan Meher 
 Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India

Correspondence Address:
Dr. Bikash Ranjan Meher
Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha
India

Pharmacopeia is the national collection of quality standards of pharmaceutical products. It is an important instrument for drug safety. The inclusion of radiopharmaceuticals (RPs) in the Indian Pharmacopeia is a step-in right direction as the adaptation of provision of pharmacopeia will reduce the unwanted adverse effects and ensure the effectiveness of RPs.


How to cite this article:
Meher BR. Inclusion of radiopharmaceuticals in the Indian pharmacopeia: A step forward.Indian J Nucl Med 2020;35:1-3


How to cite this URL:
Meher BR. Inclusion of radiopharmaceuticals in the Indian pharmacopeia: A step forward. Indian J Nucl Med [serial online] 2020 [cited 2020 Feb 24 ];35:1-3
Available from: http://www.ijnm.in/article.asp?issn=0972-3919;year=2020;volume=35;issue=1;spage=1;epage=3;aulast=Meher;type=0